Α5IA
α5IA (LS-193,268) is a nootropic drug invented in 2004 by a team working for Merck, Sharp and Dohme, which acts as a subtype-selective inverse agonist at the benzodiazepine binding site on the GABAA receptor. It binds to the α1, α2, α3 and α5 subtypes.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Α5IA
α5IA (LS-193,268) is a nootropic drug invented in 2004 by a team working for Merck, Sharp and Dohme, which acts as a subtype-selective inverse agonist at the benzodiazepine binding site on the GABAA receptor. It binds to the α1, α2, α3 and α5 subtypes.
has abstract
α5IA (LS-193,268) is a nootrop ...... he α1, α2, α3 and α5 subtypes.
@en
CAS number
215874-86-5
FDA UNII code
1M7NI1A92L
PubChem
Wikipage page ID
19,165,927
page length (characters) of wiki page
Wikipage revision ID
992,613,976
Link from a Wikipage to another Wikipage
ATC prefix
None
@en
CAS number
ChemSpiderID
drug name
α5IA
@en
IUPAC name
PubChem
SMILES
CC1=CCC2=NN=C3N2N=COCC5=CNC
@en
StdInChIKey
NZMJFRXKGUCYNP-UHFFFAOYSA-N
@en
synonyms
LS-193,268
@en
wikiPageUsesTemplate
hypernym
comment
α5IA (LS-193,268) is a nootrop ...... he α1, α2, α3 and α5 subtypes.
@en
label
Α5IA
@en
wasDerivedFrom
isPrimaryTopicOf
name
α5IA
@en